Harbour Investments, Inc. Astrazeneca PLC Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Harbour Investments, Inc. holds 8,805 shares of AZN stock, worth $567,834. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,805
Previous 8,645
1.85%
Holding current value
$567,834
Previous $674,000
1.78%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
489MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.19 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...